Article

Identifying drug sensitivity of multifocal primary prostate cancer

2023-12-13

Abstract excerpt

The pronounced intra-patient variability in multifocal primary prostate cancer (PCa) has curtailed the efficacy of current treatment options. Patient-derived organoids (PDOs) have emerged as a pivotal model for functional testing due to their capability to retain the histopathological and molecular characteristics of parental tissues, allowing timely acquisition of drug response outcomes. In our study, employing t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0900c43d-2080-5838-a999-b139dd1c051c
DOI: 10.1101/2023.12.12.569525

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identifying drug sensitivity of multifocal primary prostate cancerDOI 10.1101/2023.12.12.569525Read

A modular patient-derived organoid–xenograft platform reveals molecular and clinical trajectories of prostate cancer progressionSemantic proximity Read

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.Semantic proximity Read

A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.Semantic proximity Read

Organoids: An Emerging Precision Medicine Model for Prostate Cancer ResearchSemantic proximity Read

Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironmentSemantic proximity Read

Patient-derived xenografts and organoids model therapy response in prostate cancerSemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Patient-derived xenografts and organoids model therapy response in prostate cancer.Semantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity Read

Distinct druggable biological processes in early-onset prostate cancerSemantic proximity Read

Biobank of genetically defined murine prostate cancer tumoroids uncovers oncogenic pathways and drug vulnerabilities driven by PTEN-lossSemantic proximity Read